Analysis for UNH

📈 Growth & Financial Trajectory

Across 8 quarters, UNH shows revenue growth from about $98.9B (2024 Q2) to about $111.7B (2026 Q1), roughly a 13% increase. Net income rises from about $4.21B to about $6.48B, but quarterly results are volatile: peaks near $6.3–$6.5B early on, a drop to about $0.22B in 2025 Q4, then rebound to $6.48B in 2026 Q1.

💰 Margins & Cash Flow

Gross margins run in the high 80s to ~90%. Operating margins are variable, with 2026 Q1 showing a healthier mid-single-digit margin. Net cash from operating activities is generally positive; 2026 Q1 continuing ops yield about $8.9B. Investing and financing cash flows are often negative, with 2026 Q1 net cash flow around $3.5B from continuing operations, indicating solid operating generation and standard capital allocation.

🛡️ Balance Sheet & Liquidity

Total assets around $300–$315B and total liabilities about $190–$210B yield an equity base near $90–$105B. Current assets ≈ $90–$115B vs. current liabilities ≈ $104–$115B give a current ratio near 0.8–1.0, signaling modest liquidity. No persistent liquidity stress observed; cash flow from operations supports balance sheet resilience.

⚠️ Key Drivers & Risks

• Drivers: Enrollment growth in government and commercial health plans; scale and data analytics advantages.
• Risks: Earnings volatility from quarterly mix; regulatory/reimbursement exposure and margin sensitivity.